(3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Suppliers list
|
Company Name: |
Hubei Xinyang Medical Technology Co., Ltd
|
Tel: |
15347293736 15347293736 |
Email: |
2853117764@qq.com |
Products Intro: |
Product Name:Digoxin Impurity 16 CAS:4331-85-5 Purity:99% Package:10mg;50mg;100mg
|
Company Name: |
HX Pharmaceutical technology co., LTD
|
Tel: |
15671363360 |
Email: |
494267389@qq.com |
Products Intro: |
Product Name:Digoxin Impurity 16 CAS:4331-85-5 Purity:>95% HPLC Package:10mg;20mg;50mg;100mg
|
Company Name: |
Interbioscreen Ltd.
|
Tel: |
+7 (49) 6524-0091 |
Email: |
screen@ibscreen.chg.ru |
Products Intro: |
CAS:4331-85-5 Purity:95% Package:25mg Remarks:C23H32O6
|
|
| (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Basic information |
Product Name: | (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde | Synonyms: | (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde;Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3β,5β,17α)-;Digoxin Impurity 16 | CAS: | 4331-85-5 | MF: | C23H32O6 | MW: | 404.5 | EINECS: | | Product Categories: | | Mol File: | 4331-85-5.mol | ![(3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Structure](CAS/20180719/GIF/4331-85-5.gif) |
| (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Chemical Properties |
Boiling point | 620.7±55.0 °C(Predicted) | density | 1.432±0.06 g/cm3(Predicted) | pka | 13.92±0.70(Predicted) |
| (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Usage And Synthesis |
| (3S,5S,8R,9S,10S,13R,14S,17S)-3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde Preparation Products And Raw materials |
|